Novartis launches “not-for-profit” COVID-19 portfolio
20 July 2020
Novartis has launched a “not-for-profit” portfolio of generic and OTC medicines for symptomatic treatment of COVID-19.
You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
20 July 2020
Novartis has launched a “not-for-profit” portfolio of generic and OTC medicines for symptomatic treatment of COVID-19.
2 April 2020
Dermapharm has reported its financial results for 2019, Novartis and Aurobindo have terminated a transaction, and Stada has made a people appointment in Portugal.
26 March 2020
A consortium of healthcare companies is committing expertise and assets to the fight against the COVID-19 pandemic alongside the Bill & Melinda Gates Foundation.